What You Need to Know:
– CareFirst BlueCross BlueShield announces steps to expand access to coronavirus (COVID-19) care for its members
– CareFirst will waive prior authorizations for diagnostic tests and for covered services that are medically necessary for any members that are diagnosed with COVID-19.
CareFirst BlueCross BlueShield (CareFirst) announced it is taking action to ensure that its members seeking testing and treatment for coronavirus can swiftly access the right care in the right setting.
Actions to Help Alleviate Barriers to Coronavirus Care for Members
CareFirst will take the following actions:
1. CareFirst will waive prior authorizations for diagnostic tests and for covered services that are medically necessary and consistent with CDC guidance for any members that are diagnosed with COVID-19.
2. CareFirst will cover medically necessary diagnostic tests that are consistent with CDC guidance related to COVID-19, at no cost share to its members.
3. CareFirst will increase access to prescription medications by waiving early medication refill limits on 30-day prescription maintenance medications.
4. CareFirst encourages members to seek alternative sites of care if their primary care provider is not available, such as CareFirst’s 24-Hour Nurse Advice Line or CareFirst Video Visit, to ensure access to health services, avoid potential risks of infection and ease the burden of emergency room personnel.
The benefit changes described above apply to members in commercial fully-insured plans.
“The health and well-being of our members, associates and communities are our highest priority,” said CareFirst President and CEO, Brian D. Pieninck. “CareFirst is taking action to ensure members will not face barriers to care while seeking testing or treatment for COVID-19. We stand ready to work with our jurisdictions and public health authorities to provide support, data and expertise for the communities that we serve.”
